Ranitidine
- Oral / IVRanitidineZantac
Mechanism of Action
- Competitively inhibits action of histamine on parietal cell H2 receptors, directly resulting in suppression of acid secretion.
Clinical Use
- Indications
- Gastro-oesophageal reflux disease (GORD)
- Peptic ulcer disease (PUD)
- Scleroderma oesophagitis
- Zollinger-Ellison syndrome (gastrinoma)
Adverse Effects
- Rare.